(firstQuint)Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population.

 To describe the protectivity rate of Quadrivalent Influenza HA vaccine 28 days after immunization in Indonesian population.

 To describe immunogenicity of quadrivalent Influenza HA vaccine in all subjects.

 Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population@highlight

This study is to assess protectivity and safety of Quadrivalent Influenza Vaccine in Indonesian Population